Isin, Mustafa
Istanbul Üniversitesi,
Türkiye
2023 Rank: 702830
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General Clinical Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 373 out of 21251 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 702830 | 781372 |
| Total Cites | 1425 | 1663 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 39 | 39 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 39 | 39 |
| Composite Score | 1 | 1 |
| Number of Distinct Citing Papers | 1407 | 1645 |
| Ratio of Total Citations to Distinct Citing Papers | 1.01 | 1.01 |
| Self-Citation Percentage |
14.31%
|
|
Isin, Mustafa
Istanbul Üniversitesi,
Türkiye
2022 Rank: 563700
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General Clinical Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 297 out of 20508 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 563700 | 631184 |
| Total Cites | 1301 | 1577 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 54 | 54 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 54 | 54 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1279 | 1554 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.01 |
| Self-Citation Percentage |
17.50%
|
|
Isin, Mustafa
Istanbul Üniversitesi,
Türkiye
2021 Rank: 615712
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General Clinical Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 344 out of 20223 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 615712 | 686384 |
| Total Cites | 1550 | 1904 |
| H-index | 7 | 7 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 80 | 80 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 80 | 80 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1515 | 1869 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
18.59%
|
|
Isin, Mustafa
Istanbul Üniversitesi,
Türkiye
2020 Rank: 529538
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General Clinical Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 290 out of 16340 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 529538 | 582678 |
| Total Cites | 532 | 719 |
| H-index | 7 | 7 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 4 | 4 |
| Total Cites to Single+First Authored Papers | 81 | 81 |
| Number of Single+First+Last Authored Papers | 4 | 4 |
| Total Cites to Single+First+Last Authored Papers | 81 | 81 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 509 | 696 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.03 |
| Self-Citation Percentage |
26.01%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.